BENZGALANTAMINE GLUCONATE
| Brand name | ZUNVEYL |
|---|---|
| Active ingredient | BENZGALANTAMINE GLUCONATE |
| Strength | EQ 5MG BASE |
| Dosage form | TABLET, DELAYED RELEASE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | July 2024 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 12551491 | July 2045 | use U-713 |
| 12208167 | February 2044 | product |
| 11795176 | January 2042 | substance |
| 9763953 | December 2026 | use U-713 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.